A Hypercoagulable Hematological Metastasis Breast Cancer Model.

Area of Science:

• Oncology
• Hematology
• Biomedical Engineering

Background:

• Hypercoagulable status is a common cancer alteration, creating a cycle with hematogenous metastasis.
• A suitable model is needed to study hypercoagulable status in breast cancer metastasis.

Purpose of the Study:

• To develop and validate in vivo and in vitro models of hypercoagulable status in breast cancer.
• To investigate the role of platelet-cancer cell interactions in promoting metastasis.

Main Methods:

• Constructed 4T1-breast cancer models based on tumor-bearing period (TBP) and postoperative incubation period (PIP).
• Developed a multiple linear regression model to predict lung metastasis.
• Co-cultured platelets and 4T1 cells in vitro to analyze crosstalk and extracellular vesicle release.

Main Results:

• A predictive formula for lung metastasis was established: log10(photon number) = 0.147 TBP + 0.14 PIP + 3.303.
• Co-culturing platelets and 4T1 cells led to extracellular vesicle (EV) release and a hypercoagulable state.
• Platelet activation was identified as a key characteristic of the hypercoagulable status.

Conclusions:

• Developed in vivo and in vitro models for studying hypercoagulable status in breast cancer.
• Demonstrated that hypercoagulable status, driven by platelet activation, promotes hematogenous metastasis.
• The models facilitate further research into the mechanisms linking coagulation and cancer spread.